Select Page

STAT Plus: Beam Therapeutics raises $180 million in IPO

STAT Plus: Beam Therapeutics raises $180 million in IPO



Beam Therapeutics (BEAM), a Cambridge, Mass., genome-editing startup, raised $180 million in an initial public offering Wednesday after increasing the number of shares it offered to investors by 48 percent.

The startup offered 10.6 million shares at $17, the high end of the expected range of $15 to $17 a share. The company originally filed to raise $100 million by offering 6.3 million shares at $15 to $17 before increasing its shares by nearly half early Wednesday.



Source link

About The Author

Leave a reply

Your email address will not be published. Required fields are marked *